Search Orphan Drug Designations and Approvals
-
Generic Name: | Alpha-melanocyte stimulating hormone |
---|---|
Date Designated: | 08/19/1997 |
Orphan Designation: | Prevention and treatment of intrinsic acute renal failure due to ischemia. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
National Institute of Diabetes, and Digestive and Kidney Diseases National Institutes of Health, 31 Center Drive MSC Building 31, Room 9N-222 Bethesda, Maryland 20892 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-